Mycelex-g From Bayer Pharms With Clotrimazole 500mg

Ingredients: Clotrimazole
Dosage Form and Administration: Tablet; Vaginal
Drug Trade Name: Mycelex-g
Firm: Bayer Pharms
Strength: 500MG
New Drug Application Type: N
Drug Application Number:19069
Product Number: 1
Approval Date: 4/19/1985
Reference Listed Drug: No
Type: DISCN
Applicant Full Name: Bayer Pharmaceuticals Corp

Facility that Meets Needs and Budget

The next step seeking treatment is to locate the right treatment facility to meet the needs and budget. Whether an inpatient hospital or residential treatment center specializing in addiction treatment or outpatient treatment, determine which treatment facility can best address the particular addiction situation.

The following step is to contact each of the treatment providers on the list and ask a series of questions. Some people may visit the clinics that seem well-matched in order to see firsthand how these facilities operate and to get a better sense of the kind of care a patient will be receiving at the facility. Ask for literature and inquire about all costs associated with the treatment and various treatment options each may offer. Some residential treatment facilities, for example, offer outpatient treatment, aftercare treatment and other services.

In order to shorten a long list of possible treatment facilities it is best to examine in-depth exactly what the costs of the programs are. Some facilities require an initial assessment first, in order for professional staff to determine the best and personalized program for a patient. In fact, whichever treatment facility ultimately chooses, no treatment can begin without a comprehensive assessment. This assessment involves an interview to learn about patient background, family history, type of substance and duration of abuse and other issues important to the treatment. Some treatment centers require patient detoxification in order to be admitted to the treatment program. This will be determined at the time of the assessment. No one can enter treatment without being free of traces of drugs or alcohol.

Co-Occurring Drug Abuse and Mental Health

Offenders with co-occurring drug abuse and mental health problems often require an integrated treatment approach. High rates of mental health problems are present in offender populations and in those with substance abuse problems. Drug abuse treatment can sometimes address depression, anxiety and other mental health problems. Personality, cognitive and other serious mental disorders can be difficult to treat and may disrupt drug treatment. The presence of co-occurring disorders may require an integrated approach that combines drug abuse treatment with psychiatric treatment, including the use of medication. A physician should assess Individuals with either a substance abuse or mental health problem for the presence of the other.

Medications for Drug Abuse

Medications are important parts of treatment for many drug abusing offenders. For heroin addiction, medicines such as methadone and buprenorphine help normalize brain function and individuals who may benefit from them should take them. Effective use of medications can be instrumental in enabling people with co-occurring mental health problems to function successfully in society. Behavioral strategies can increase adherence to medication regimens.

Chronic Conditions Prevention

Treatment planning for drug abusing offenders who are living in or returning the community should include strategies to prevent and treat serious, chronic medical conditions, such as HIV/AIDS, hepatitis B and C and tuberculosis.
The rates of infectious diseases, such as hepatitis, tuberculosis and HIV/AIDS, are higher in drug abusers, incarcerated offenders and offenders under community supervision than in the general population. Infectious diseases affect not just the offender, but also the criminal justice system and the wider community. Consistent with federal and state laws, offenders who have abused drugs should be tested for infectious diseases and receive counseling on health practices and on ways to modify risky behaviors. Probation and parole officers who monitor offenders with serious medical conditions should link them with appropriate healthcare services, encourage compliance with medical treatment and re-establish eligibility of the offender for public health services like Medicaid.